Option Care Health Stock Forecast

Stock Price Forecast

According to 13 analysts polled by S&P Global, Option Care Health stock has a consensus rating of "Buy" and an average price target of $28.58. The average 1-year stock price forecast is 16.65% higher than the current stock price, while the lowest is $23 (-6.12%) and the highest is $39 (+59.18%).

Price Target: $28.58 (+16.65%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$23	$28.58	$28	$39
Change	-6.12%	+16.65%	+14.29%	+59.18%

Analyst Ratings

The average analyst rating for Option Care Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	Mar '26	Apr '26	May '26	Jun '26	Jul '26	Aug '26
Strong Buy	7	7	6	6	4	4
Buy	4	4	4	4	4	4
Hold	1	1	2	3	5	5
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	12	12	12	13	13	13

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Charles Rhyee TD Cowen	TD Cowen	Hold Maintains $23	Hold	Maintains	$23	-6.12%	Aug 3, 2026
Michael Petusky Barrington	Barrington	Buy Maintains $32 → $33	Buy	Maintains	$32 → $33	+34.69%	Jul 30, 2026
David S Macdonald Truist Financial	Truist Financial	Buy Reiterates $30	Buy	Reiterates	$30	+22.45%	Jul 30, 2026
Joanna Gajuk Bank of America Securities	Bank of America Securities	Hold Reiterates $25	Hold	Reiterates	$25	+2.04%	Jul 30, 2026
Pito Chickering Deutsche Bank	Deutsche Bank	Hold Downgrades $26 → $24	Hold	Downgrades	$26 → $24	-2.04%	Jul 30, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

5.75B

from 5.65B

1.83%

from 5.65B

Revenue Next Year

6.13B

from 5.75B

6.61%

from 5.75B

EPS This Year

1.88

from 1.72

9.43%

from 1.72

EPS Next Year

2.08

from 1.88

10.61%

from 1.88

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	3.44B	3.94B	4.30B	5.00B	5.65B	5.75B
Revenue Growth	13.39%	14.72%	9.07%	16.17%	13.03%	1.83%
Gross Profit	779.61M	866.92M	981.22M	1.01B	1.09B	1.10B
Gross Margin	22.67%	21.98%	22.81%	20.27%	19.26%	19.07%
Operating Income	190.84M	240.23M	314.60M	321.83M	337.91M	372.14M
Net Income	139.90M	150.56M	267.09M	211.82M	207.59M	229.95M
EPS	-	-	-	-	1.72	1.88
EPS Growth	-	-	-	-	34.87%	9.43%
Forward PE	32.40	33.52	29.76	19.18	21.54	13.02
Free Cash Flow	141.52M	175.25M	222.48M	235.36M	172.75M	275.59M
No. Analysts	-	-	-	-	-	13

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	5.8B
Avg	5.8B
Low	5.7B

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	2.2%
Avg	1.8%
Low	1.0%

EPS Forecast

Chart

EPS	2026	2027	2028
High	1.92
Avg	1.88
Low	1.86

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	11.6%
Avg	9.4%
Low	7.9%